All News

A prostate cancer expert lends insight to the nationwide Pluvicto shortage, and what eligible patients can do.

The Food and Drug Administration will review Braftovi plus Mektovi for the treatment of patients with metastatic BRAF V600E-mutant non-small cell lung cancer.

While I wouldn’t say that my cancer-related hospital stays were fun, I did my best to maintain a positive attitude and make the best of them.

Cryocompression was found to be tolerable and effective in preventing chemotherapy-induced peripheral neuropathy in a small study.

Sometimes, hundreds of pages of cancer information still just doesn’t connect with the person who needs it.

Researchers determined that mortality rates did not differ in men with localized prostate cancer if they underwent active monitoring, prostatectomy or radiotherapy.

A phase 1/1b trial will examine PRGN-3007 in patients with ROR1-positive hematologic and solid cancers.

The FDA approved the combination for patients with locally advanced or metastatic urothelial carcinoma who are ineligible for treatment with cisplatin-based chemotherapy.

As caregivers become more integrated into the health care delivery process for patients with cancer, their own needs should still be focused on pertaining to mental and physical health.

Patients with cancer may decide to share their diagnosis with their employer but approaching it in a way that is most comfortable to the patient may make it a more effective conversation.

There is no guidebook to life with cancer, but here a few important lessons I learned along the way.

While waiting for my daughter to get a prophylactic cancer surgery, I sketched a cartoon that I hope will get people talking about hereditary cancer risks.

People who have never experienced cancer may think that life continues as normal after treatment is done, but that’s far from reality.

Watch Dr. Rupesh Kotecha, from Miami Cancer Institute, Baptist Health South Florida, discuss the treatment of brain metastases during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Patients with HR+/HER2- early breast cancer treated with the CDK4/6 inhibitor plus endocrine therapy in the phase 3 NATALEE trial had a reduced risk for the cancer to recur.

Two-year follow-up data showed that Rybrevant was promising in a difficult-to-treat subtype of non-small cell lung cancer.

After being diagnosed with Lynch syndrome, a hereditary cancer syndrome, I saw my imperfect situation as an opportunity to educate and connect with others.

From the San Diego Padres’ coach missing Opening Day for colon cancer surgery to WWE star Alexa Bliss sharing her skin cancer experience and warning people against tanning beds, here’s what’s happening in the oncology space this week.

Watch Dr. Ana C. Sandoval Leon, from Miami Cancer Institute, Baptist Health South Florida, discuss HER2-positive metastatic disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

In this Educated Patient® webinar, CURE® spoke with experts from Allegheny Health Network about addressing disparities in diversity, equity and inclusion in cancer care.

Cancer survivors shared why they disclosed — or didn’t disclose — their cancer diagnosis to their employers.

After being diagnosed with cancer and taking a look at all the stuff I accumulated, I began to think about my priorities in life.

The current testing rate for BRCA 1/2 mutations is currently 68% in HER2-negative early breast cancer, but eligible patients could receive better care if tested.

Watch Dr. Naomi Dempsey, from Miami Cancer Institute, discuss the management of HER2-positive, early-stage disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

My cancer diagnosis — and the emotional effects that came with it — made me who I am today.

The Food and Drug Administration approved Keytruda for adult and pediatric patients with previously treated unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors.

Antibody drug conjugates, which are used to treat various types of cancer, can cause eye issues, though they are easily treated if caught early, one expert said.

The way I see it, double the cancer diagnoses means double the victory.